4//SEC Filing
Poulton Stuart 4
Accession 0001193125-25-241484
CIK 0001503802other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:32 PM ET
Size
4.8 KB
Accession
0001193125-25-241484
Insider Transaction Report
Form 4
Poulton Stuart
EVP, Chief Development Officer
Transactions
- Award
Common Stock
2025-10-15+39,682→ 67,392 total
Footnotes (1)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001942597
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:32 PM ET
- Size
- 4.8 KB